Chemical & Pharmaceutical Capability in Asia
Whilst sales of generic medicines are booming in the emerging markets like China, India and Singapore, research-focused bio-pharmaceutical companies are investing in their R&D programs to try and produce a small volume of breakthrough products that will shape the future of the pharmaceuticals market.
Similarly, within the Chemicals sector it indicates that 2/3 of total global demand for Chemicals will come from within Asia.
As a result, to drive greater success of their investment and to deliver increasing shareholder value, multi-nationals will need a strategy and the necessary governance in place to minimize risks, ensure the high quality of delivery and a higher capital return.
Share this page viaMail
With over 50 offices in Asia spread across 12 countries, we support our clients wherever they need us.
We offer a wide range of services that help our clients to address challenges in built and natural environments.